HERANTIS PHARMA

IPO

HERANTIS PHARMA is a biotech company in Helsinki, Finland, founded in 2008. It has raised $18.6M across 3 rounds, most recently a $4.6M Venture Round in February 2026.

Innovative therapies for better lives

Headquarters
Helsinki
Founded
2008
Business Model
B2B
Total Funding
$18.6M
Last Round
$4.6M Venture RoundFeb 2026
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Herantis Pharma develops neurorestorative therapies aimed at slowing or stopping the progression of Parkinson’s disease. Its lead product, HER-096, is a CDNF-derived peptidomimetic targeting proteostasis imbalance, mitochondrial dysfunction, and neuroinflammation through modulation of the unfolded protein response. The company pursues strategic partnerships for late-stage clinical development and commercialization.

Summary

It has raised $18.6M in total across 3 rounds, most recently a $4.6M Venture Round in Feb 2026. Investors include European Innovation Council Fund.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Venture RoundVenture RoundFeb 2026
$4.6M

Sign up to see all 4 events

Funding: Grant through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HERANTIS PHARMA on Indexed.vc
<a href="https://indexed.vc/companies/herantis-pharma"><img src="https://indexed.vc/api/badge/company/herantis-pharma" alt="HERANTIS PHARMA on Indexed.vc" width="260" height="76" /></a>